Executive Order 14120 · 2024-03-21

Advancing Women's Health Research and Innovation

Federal Agencies Directed to Boost Research on Women's Health

Share
Signed by Joseph R. Biden Jr.
Published 2024-03-21

What it does

Agencies must strengthen research and data standards, prioritize women's health funding, and report on progress within set timelines.

Real-world impact

  • Prioritizes federal grants and awards for studies focused on women's health.
  • Requires new reporting and recruitment steps for clinical trials enrolling women.
  • Launches national menopause and midlife research and public information resources.

Topics

women's health researchclinical trialsfunding and grantsmenopause and midlife healthresearch data standards

Summary

This order directs federal agencies to expand and improve research on women's health across lifespans, strengthen study design and data standards, and increase women's participation in clinical trials. It mobilizes the White House Initiative on Women's Health Research and agency leaders to prioritize grantmaking, spur innovation and small-business involvement, and develop new menopause and midlife research and public resources. The stated goal is to close gaps in knowledge, reduce health disparities, and turn research discoveries into better, evidence-based care for women.

Ask this order

Questions, answered

Ask questions about this executive order and its implications. Try:

  • “What agencies are affected by this order?”
  • “How does this order change existing policy?”
  • “What are the practical implications of this order?”

Related Executive Orders